Literature DB >> 22379111

Resistant hypertension: incidence, prevalence, and prognosis.

Eduardo Pimenta, David A Calhoun.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22379111      PMCID： PMC3350774          DOI： 10.1161/CIRCULATIONAHA.112.097345

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  15 in total

1.  Hyperaldosteronism among black and white subjects with resistant hypertension.

Authors:  David A Calhoun; Mari K Nishizaka; Mohammad A Zaman; Roopal B Thakkar; Paula Weissmann
Journal:  Hypertension       Date:  2002-12       Impact factor: 10.190

2.  Success and predictors of blood pressure control in diverse North American settings: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT).

Authors:  William C Cushman; Charles E Ford; Jeffrey A Cutler; Karen L Margolis; Barry R Davis; Richard H Grimm; Henry R Black; Bruce P Hamilton; Joanne Holland; Chuke Nwachuku; Vasilios Papademetriou; Jeffery Probstfield; Jackson T Wright; Michael H Alderman; Robert J Weiss; Linda Piller; Judy Bettencourt; Sandra M Walsh
Journal:  J Clin Hypertens (Greenwich)       Date:  2002 Nov-Dec       Impact factor: 3.738

3.  Incidence and prognosis of resistant hypertension in hypertensive patients.

Authors:  Stacie L Daugherty; J David Powers; David J Magid; Heather M Tavel; Frederick A Masoudi; Karen L Margolis; Patrick J O'Connor; Joe V Selby; P Michael Ho
Journal:  Circulation       Date:  2012-02-29       Impact factor: 29.690

4.  Heart disease and stroke statistics--2011 update: a report from the American Heart Association.

Authors:  Véronique L Roger; Alan S Go; Donald M Lloyd-Jones; Robert J Adams; Jarett D Berry; Todd M Brown; Mercedes R Carnethon; Shifan Dai; Giovanni de Simone; Earl S Ford; Caroline S Fox; Heather J Fullerton; Cathleen Gillespie; Kurt J Greenlund; Susan M Hailpern; John A Heit; P Michael Ho; Virginia J Howard; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; Diane M Makuc; Gregory M Marcus; Ariane Marelli; David B Matchar; Mary M McDermott; James B Meigs; Claudia S Moy; Dariush Mozaffarian; Michael E Mussolino; Graham Nichol; Nina P Paynter; Wayne D Rosamond; Paul D Sorlie; Randall S Stafford; Tanya N Turan; Melanie B Turner; Nathan D Wong; Judith Wylie-Rosett
Journal:  Circulation       Date:  2010-12-15       Impact factor: 29.690

5.  Independent relations of left ventricular structure with the 24-hour urinary excretion of sodium and aldosterone.

Authors:  Yu Jin; Tatiana Kuznetsova; Marc Maillard; Tom Richart; Lutgarde Thijs; Murielle Bochud; Marie-Christine Herregods; Michel Burnier; Robert Fagard; Jan A Staessen
Journal:  Hypertension       Date:  2009-07-06       Impact factor: 10.190

6.  Low-renin status in therapy-resistant hypertension: a clue to efficient treatment.

Authors:  Ivar K Eide; Peter A Torjesen; Anders Drolsum; Almira Babovic; Nils P Lilledahl
Journal:  J Hypertens       Date:  2004-11       Impact factor: 4.844

7.  Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients.

Authors:  Kenneth Jamerson; Michael A Weber; George L Bakris; Björn Dahlöf; Bertram Pitt; Victor Shi; Allen Hester; Jitendra Gupte; Marjorie Gatlin; Eric J Velazquez
Journal:  N Engl J Med       Date:  2008-12-04       Impact factor: 91.245

8.  Effects of dietary sodium reduction on blood pressure in subjects with resistant hypertension: results from a randomized trial.

Authors:  Eduardo Pimenta; Krishna K Gaddam; Suzanne Oparil; Inmaculada Aban; Saima Husain; Louis J Dell'Italia; David A Calhoun
Journal:  Hypertension       Date:  2009-07-20       Impact factor: 10.190

9.  Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research.

Authors:  David A Calhoun; Daniel Jones; Stephen Textor; David C Goff; Timothy P Murphy; Robert D Toto; Anthony White; William C Cushman; William White; Domenic Sica; Keith Ferdinand; Thomas D Giles; Bonita Falkner; Robert M Carey
Journal:  Hypertension       Date:  2008-04-07       Impact factor: 10.190

10.  Relation of dietary salt and aldosterone to urinary protein excretion in subjects with resistant hypertension.

Authors:  Eduardo Pimenta; Krishna K Gaddam; Monique N Pratt-Ubunama; Mari K Nishizaka; Inmaculada Aban; Suzanne Oparil; David A Calhoun
Journal:  Hypertension       Date:  2007-12-17       Impact factor: 10.190
View more
  66 in total

1.  Capsule commentary on Fontil, et al. physician underutilization of effective medications for resistant hypertension at office visits in the United States: NAMCS 2006-2010.

Authors:  Idris Guessous
Journal:  J Gen Intern Med       Date:  2014-03       Impact factor: 5.128

2.  Apparent treatment-resistant hypertension and risk for stroke, coronary heart disease, and all-cause mortality.

Authors:  Marguerite R Irvin; John N Booth; Daichi Shimbo; Daniel T Lackland; Suzanne Oparil; George Howard; Monika M Safford; Paul Muntner; David A Calhoun
Journal:  J Am Soc Hypertens       Date:  2014-03-15

3.  Prevalence and correlates of low medication adherence in apparent treatment-resistant hypertension.

Authors:  Marguerite R Irvin; Daichi Shimbo; Devin M Mann; Kristi Reynolds; Marie Krousel-Wood; Nita A Limdi; Daniel T Lackland; David A Calhoun; Suzanne Oparil; Paul Muntner
Journal:  J Clin Hypertens (Greenwich)       Date:  2012-08-03       Impact factor: 3.738

Review 4.  Renal denervation therapy for resistant hypertension: a clinical update.

Authors:  C V S Ram; A S Kumar
Journal:  J Hum Hypertens       Date:  2014-03-06       Impact factor: 3.012

5.  Renal nerve ablation after SYMPLICITY HTN-3: confused at the higher level?

Authors:  Thomas F Lüscher; Felix Mahfoud
Journal:  Eur Heart J       Date:  2014-05-14       Impact factor: 29.983

Review 6.  Oh, the places you'll go! My many colored serotonin (apologies to Dr. Seuss).

Authors:  Stephanie W Watts
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-09-23       Impact factor: 4.733

7.  Renal denervation by ablation with innovative technique in resistant hypertension.

Authors:  Luiz Aparecido Bortolotto; Thiago Midlej-Brito; Cristiano Pisani; Valéria Costa-Hong; Maurício Scanavacca
Journal:  Arq Bras Cardiol       Date:  2013-10       Impact factor: 2.000

Review 8.  How can resistant hypertension be identified and prevented?

Authors:  Anna Solini; Luis M Ruilope
Journal:  Nat Rev Cardiol       Date:  2013-03-05       Impact factor: 32.419

9.  Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association.

Authors:  Robert M Carey; David A Calhoun; George L Bakris; Robert D Brook; Stacie L Daugherty; Cheryl R Dennison-Himmelfarb; Brent M Egan; John M Flack; Samuel S Gidding; Eric Judd; Daniel T Lackland; Cheryl L Laffer; Christopher Newton-Cheh; Steven M Smith; Sandra J Taler; Stephen C Textor; Tanya N Turan; William B White
Journal:  Hypertension       Date:  2018-11       Impact factor: 10.190

10.  Prevalence of electrocardiographic abnormalities based on hypertension severity and blood pressure levels: the Reasons for Geographic and Racial Differences in Stroke study.

Authors:  Hemal Bhatt; Christopher M Gamboa; Monika M Safford; Elsayed Z Soliman; Stephen P Glasser
Journal:  J Am Soc Hypertens       Date:  2016-06-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.